Responsiveness to Vasoconstrictor Therapy in Hepatorenal Syndrome Type 1

KEY POINTS: Raising the mean arterial pressure (MAP) during management of hepatorenal syndrome type 1 (HRS-1) is associated with improvement in kidney function, independently of baseline MAP or model for end-stage liver disease. Raising the MAP by 15 mm Hg or greater leads to greater reduction in se...

Descripción completa

Detalles Bibliográficos
Autores principales: Velez, Juan Carlos Q., Karakala, Nithin, Tayebi, Kasra, Wickman, Terrance J., Mohamed, Muner M. B., Kovacic, Rosemary A., Therapondos, George, Kanduri, Swetha R., Allegretti, Andrew S., Belcher, Justin M., Regner, Kevin R., Wentowski, Cathy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Nephrology 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278824/
https://www.ncbi.nlm.nih.gov/pubmed/36763632
http://dx.doi.org/10.34067/KID.0000000000000068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278824/
https://www.ncbi.nlm.nih.gov/pubmed/36763632
http://dx.doi.org/10.34067/KID.0000000000000068

Ejemplares similares